ISB News

Tackling Lyme Disease with Immunity

It’s Lyme disease season in many areas of the United States, including the Northeast, the Midwest, and some places on the West Coast. About 30,000 Lyme disease cases are reported to the Centers for Disease Control and Prevention each year, but that number is likely far lower than the actual number of people diagnosed each year. Some estimates suggest that nearly 500,000 people get Lyme disease annually in the U.S. alone.

ISB Associate Professor Dr. Naeha Subramanian participated in ISB’s latest Research Roundtable event. Lyme disease is just one of the research areas studied by the Subramanian Lab. Subramanian delivered a presentation called “Tackling Lyme Disease with Immunity,” which you can watch here or by clicking play on the video at the top of this story.

Research Roundtables

ISB is hosting a series of Research Roundtable conversations throughout 2021 that will feature our leading scientists discussing their latest research. These events are designed for the novice scientist and the expert alike, and are open to anyone interested in the topics. Featured scientists will also answer your questions.

Next up in our series is Dr. Andrew Magis, who on September 21 will discuss identifying markers for cancer years before diagnosis (sign up here).

Past Research Roundtable events have featured ISB Co-founder Dr. Lee Hood, microbiome specialist and ISB Assistant Professor Dr. Sean Gibbons, and Alzheimer’s disease expert and ISB Senior Research Scientist Dr. Jared Roach. You can read about their talks and watch their presentations here, here and here, respectively.

Recent Articles

  • Timing is Everything: ISB Study Finds Link Between Bowel Movement Frequency and Overall Health

    Everybody poops, but not every day. An ISB-led research team examined the clinical, lifestyle, and multi-omic data of more than 1,400 healthy adults. How often people poop, they found, can have a large influence on one’s physiology and health.

  • Wei Wei, PhD

    Dr. Wei Wei Promoted to Associate Professor

    Wei Wei, PhD – an accomplished cancer researcher with expertise in biotechnology and cancer systems biology – has been promoted to ISB associate professor. The Wei Lab focuses on understanding how cancer cells adapt to therapeutic treatment to foster therapy resistance by coordinating their internal molecular machinery and how these adaptive changes evolve within diverse tumors influenced by the tumor microenvironment. 

  • Drs. Nitin Baliga and James Park

    How Glioblastoma Resists Treatment – and Ways to Prevent It

    Glioblastoma is one of the deadliest and most aggressive forms of primary brain cancer in adults and is known for its ability to resist treatment and to recur. ISB researchers have made breakthrough discoveries in understanding the mechanisms behind acquired resistance, focusing on a rare and stubborn group of cells within tumors called glioma stem-like cells.